SCHEMBL3363435

SCHEMBL3363435

CN1CCCN(c2cncc(-c3ccc(C=C4SC(=S)NC4=O)o3)n2)CC1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIM1 P11309 5/20 0.47
PIM2 Q9P1W9 6/20 0.47
MEN1 O00255 1/20 0.46
LMNA P02545 1/20 0.46
POLB P06746 1/20 0.46
GAA P10253 1/20 0.46
PKM P14618 1/20 0.46
HPGD P15428 1/20 0.46
KMT2A Q03164 1/20 0.46
NPSR1 Q6W5P4 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
INSR P06213 2/20 0.43
IGF1R P08069 2/20 0.43
HSPD1 P10809 1/20 0.42
HSPE1 P61604 1/20 0.42
PTP4A3 O75365 1/20 0.41
CSNK2A2 P19784 1/20 0.41
CSNK2A1 P68400 1/20 0.41
ADAMTS5 Q9UNA0 1/20 0.41
GSK3B P49841 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3363428 1.00 PIM1 (0.47) PIM1PIM2MEN1LMNAPOLB
SCHEMBL12990160 1.00 PIM1 (0.47) PIM1PIM2MEN1LMNAPOLB
SCHEMBL3367012 0.92 PIK3CG (0.48) PIM1PIM2INSRIGF1RCSNK2A2
SCHEMBL12990281 0.92 PIK3CG (0.48) PIM1PIM2INSRIGF1RCSNK2A2
SCHEMBL3367020 0.92 PIK3CG (0.48) PIM1PIM2INSRIGF1RCSNK2A2
SCHEMBL12990442 0.84 PIM2 (0.48) PIM1PIM2MEN1LMNAPOLB
SCHEMBL3363795 0.81 PIM1 (0.50) PIM1PIM2MEN1POLBKMT2A
SCHEMBL3363799 0.81 PIM1 (0.50) PIM1PIM2MEN1POLBKMT2A
SCHEMBL3366398 0.81 PIM2 (0.60) PIM1PIM2CSNK2A2CSNK2A1ADAMTS5
SCHEMBL12990158 0.81 PIM2 (0.60) PIM1PIM2CSNK2A2CSNK2A1ADAMTS5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100331315-A1 RHODANINES AND RELATED HETEROCYCLES AS KINASE INHIBITORS SENHWA BIOSCIENCES, INC. (TW) 2010-12-30 US disclosed
WO-2010148351-A1 RHODANINES AND RELATED HETEROCYCLES AS KINASE INHIBITORS CYLENE PHARMACEUTICALS, INC. (US) 2010-12-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100331315-A1 RHODANINES AND RELATED HETEROCYCLES AS KINASE INHIBITORS PIM2, PIM1, CDK2 PIM1 2/4885PIM2 1/4885MEN1 2930/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.